Prelude Capital Management’s Replimune Group REPL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-26,763
Closed -$112K 1514
2025
Q3
$112K Sell
26,763
-97,017
-78% -$620K 0.01% 1041
2025
Q2
$1.15M Buy
123,780
+41,218
+50% +$360K 0.11% 229
2025
Q1
$805K Buy
82,562
+66,244
+406% +$820K 0.06% 360
2024
Q4
$198K Buy
+16,318
New +$198K 0.01% 1004
2020
Q4
Sell
-4,400
Closed -$101K 1859
2020
Q3
$101K Buy
+4,400
New +$100K ﹤0.01% 904
2019
Q3
Sell
-505
Closed -$7K 1982
2019
Q2
$7K Buy
+505
New +$7.3K ﹤0.01% 1466

Other funds holding REPL

Prelude Capital Management's REPL Position: Q4 2025 in Review

Prelude Capital Management sold out of Replimune Group (REPL) in Q4 2025, closing a stake of 26,763 shares — an estimated $112K sold.

Prelude Capital Management first reported a position in REPL in Q2 2019 and held it in 6 quarters. The position peaked at $1.15M in Q2 2025. 164 funds tracked by Wall St. Rank hold REPL as of Q4 2025.

  • Prelude Capital Management reported no remaining Replimune Group position as of Q4 2025 after selling out during the quarter.
  • Prelude Capital Management sold 26,763 Replimune Group shares in Q4 2025, an estimated $112K.
  • Prelude Capital Management first reported a position in Replimune Group in Q2 2019 and held it in 6 quarters.
  • Prelude Capital Management's Replimune Group position peaked at $1.15M in Q2 2025.
  • 164 funds tracked by Wall St. Rank held Replimune Group as of Q4 2025.

Based on Prelude Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.